Abstracts
Speaker Abstracts
Poster Abstracts
P. Burke
J.D. Furber
J. Graham
L.S. Graham
J. Greeson
J.C. Guerin
S. Gupta
D. Hickman
J.P. Jackson III
J. Kaur
A. Khalyavkin
K. Kruse
M. Mangin
H. Mohammadpour
C.E. Mykytyn
S.T. Parish
O. Pawlik
A. Proal
D. Stubbs
S. Tanglao
B. Villeponteau
X.J. Wang
J. Wheeler
D. Yin
Manipulation of TNFalpha delays the loss of CD28 in human CD8 T cells via the caspase-3 pathway
S.T. Parish, R.B. Effros
University of California, Los Angeles, Los Angeles, CA
Increased proportions of CD8 T cells lacking expression of the CD28 co-stimulatory receptor and having short telomeres are associated with numerous deleterious clinical outcomes in the elderly, including decreased vaccine responsiveness and early mortality. Cells with a similar phenotype arise in cell culture following multiple rounds of antigen-driven proliferation. In addition to the cell cycle arrest and loss of CD28 expression, senescent CD8 T cells secrete high titers of the pro-inflammatory cytokine, TNFalpha.
Since TNFalpha has been shown to bind one of the CD28 promoter regions, we tested whether antibody-mediated neutralization of the TNFalpha present in the culture supernatant would affect CD28 expression. Human T cells that were repeatedly stimulated in vitro with antigen in the presence of anti-TNFalpha showed prolonged expression of both the CD28 receptor and CD28 transcript, as well as increased proliferative potential. Consistent with the role of CD28 signal transduction in T cell telomerase upregulation, the prolonged expression of CD28 was associated with increased telomerase activity. Finally, based on reports showing that nuclear localization of caspase-3 leads to CD28 down-regulation, we evaluated the expression of caspase-3 in the anti-TNFalpha-treated cultures. Indeed, prolonged CD28 expression induced by anti-TNFalpha was associated with lower constitutive levels of caspase-3 activity. The inverse association between CD28 expression and caspase-3 was also seen in CD8 T cells tested immediately ex vivo: We separated CD8+CD28+ and CD8+CD28- from peripheral blood samples of healthy donors, and measured the constitutive caspase-3 activity levels in each population. The caspase-3 activity was significantly greater in the CD8+CD28- population, as compared to their CD28+ counterparts.
Our data suggest that loss of CD28 expression is caused by increased caspase-3 activity that can be induced by TNFalpha. These studies help elucidate the pathway involved in the senescence-associated loss of CD28 expression, and also suggest possible strategies for retarding the generation of senescent CD8 T cells during aging in vivo. (Supported by NIH AG 023720 & AI 060362)
Keywords: Senescence, CD28, TNFalpha, Caspase-3